O uso de psicotrópicos antes e depois da pandemia: o cuidado farmacêutico como serviço relevante para um tratamento seguro.

Abstract

The COVID-19 pandemic has brought several consequences to the world's population, including the worsening of depression and anxiety rates and the increase in the population's consumption of psychotropic medications. Therefore, the present work aimed to compare the consumption of psychotropic drugs before and after the pandemic, emphasizing the importance of Pharmaceutical Care for safe and effective treatment. This study is an integrative review of the literature carried out through the following bibliographic databases: Pubmed, Lilacs, Scielo, Google Scholar and health committees, between the years 2019 and 2024. 66 articles were found, of which 56 were selected to compose this review, in addition to 04 documents found on websites such as PAHO/WHO. The studies analyzed demonstrated that in the period prior to the COVID-19 pandemic, the consumption of psychotropic medications was already quite significant, a rate that has increased considerably since 2020. Therefore, given the potential risks that the irrational use of psychotropic medications can bring to the individual, it is concluded that the pharmacist is a necessary professional in the field of mental health, as through Pharmaceutical Care he contributes to the effectiveness and safety of the patient's pharmacotherapy.